Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System

od Wiedemeyer, W. Ruprecht, Beach, Jessica A., Karlan, Beth Y.
Wydane 2014

Correlation of Glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells

od Beach, Jessica A., Nary, Laura J., Hovanessian, Rebeka, Medh, Rheem D.
Wydane 2014

E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim

od Beach, Jessica A, Nary, Laura J, Hirakawa, Yasuko, Holland, Eli, Hovanessian, Rebeka, Medh, Rheem D
Wydane 2011

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation

od Liu, Zhenqiu, Beach, Jessica A., Agadjanian, Hasmik, Jia, Dongyu, Aspuria, Paul-Joseph, Karlan, Beth Y., Orsulic, Sandra
Wydane w Gynecol Oncol (2015)

Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer

od Beach, Jessica A., Aspuria, Paul-Joseph P., Cheon, Dong-Joo, Lawrenson, Kate, Agadjanian, Hasmik, Walsh, Christine S., Karlan, Beth Y., Orsulic, Sandra
Wydane w Oncotarget (2015)

ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma

od Cheon, Dong-Joo, Li, Andrew J., Beach, Jessica A., Walts, Ann E., Tran, Hang, Lester, Jenny, Karlan, Beth Y., Orsulic, Sandra
Wydane w Carcinogenesis (2015)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas

od Cheon, Dong‐Joo, Walts, Ann E, Beach, Jessica A, Lester, Jenny, Bomalaski, John S, Walsh, Christine S, Ruprecht Wiedemeyer, W, Karlan, Beth Y, Orsulic, Sandra
Wydane w J Pathol Clin Res (2014)

A collagen-remodeling gene signature regulated by TGFβ signaling is associated with metastasis and poor survival in serous ovarian cancer

od Cheon, Dong-Joo, Tong, Yunguang, Sim, Myung-Shin, Dering, Judy, Berel, Dror, Cui, Xiaojiang, Lester, Jenny, Beach, Jessica A., Tighiouart, Mourad, Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Wydane 2013

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism

od Aspuria, Paul-Joseph P, Lunt, Sophia Y, Väremo, Leif, Vergnes, Laurent, Gozo, Maricel, Beach, Jessica A, Salumbides, Brenda, Reue, Karen, Wiedemeyer, W Ruprecht, Nielsen, Jens, Karlan, Beth Y, Orsulic, Sandra
Wydane w Cancer Metab (2014)

Going to extremes: determinants of extraordinary response and survival in patients with cancer

od Saner, Flurina A. M., Herschtal, Alan, Nelson, Brad H., deFazio, Anna, Goode, Ellen L., Ramus, Susan J., Pandey, Ahwan, Beach, Jessica A., Fereday, Sian, Berchuck, Andrew, Lheureux, Stephanie, Pearce, Celeste Leigh, Pharoah, Paul D., Pike, Malcolm C., Garsed, Dale W., Bowtell, David D. L.
Wydane w Nat Rev Cancer (2019)

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models

od Morrish, Emma, Copeland, Anthony, Moujalled, Donia M., Powell, Jason A., Silke, Natasha, Lin, Ann, Jarman, Kate E., Sandow, Jarrod J., Ebert, Gregor, Mackiewicz, Liana, Beach, Jessica A., Christie, Elizabeth L., Lewis, Alexander C., Pomilio, Giovanna, Fischer, Karla C., MacPherson, Laura, Bowtell, David D. L., Webb, Andrew I., Pellegrini, Marc, Dawson, Mark A., Pitson, Stuart M., Wei, Andrew H., Silke, John, Brumatti, Gabriela
Wydane w Blood Adv (2020)